| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 17 | 2025 | 1031 | 1.450 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2022 | 567 | 1.030 |
Why?
|
| Myelin Proteins | 2 | 2016 | 78 | 0.930 |
Why?
|
| Hand Deformities, Congenital | 3 | 2021 | 95 | 0.880 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 210 | 0.810 |
Why?
|
| INDEL Mutation | 2 | 2020 | 94 | 0.760 |
Why?
|
| Genetic Testing | 4 | 2026 | 1100 | 0.750 |
Why?
|
| Transcription Factors | 6 | 2025 | 2452 | 0.710 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 157 | 0.700 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 10 | 0.690 |
Why?
|
| Micrognathism | 1 | 2021 | 64 | 0.690 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 967 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 137 | 0.650 |
Why?
|
| Chromosome Disorders | 3 | 2019 | 317 | 0.640 |
Why?
|
| Rare Diseases | 1 | 2022 | 207 | 0.640 |
Why?
|
| Gene Duplication | 3 | 2016 | 360 | 0.620 |
Why?
|
| Chromosome Duplication | 4 | 2018 | 147 | 0.610 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2016 | 364 | 0.610 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2025 | 174 | 0.590 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 1543 | 0.580 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 28 | 0.570 |
Why?
|
| Genomics | 5 | 2024 | 1619 | 0.550 |
Why?
|
| Haploinsufficiency | 5 | 2021 | 263 | 0.540 |
Why?
|
| Gene Deletion | 2 | 2021 | 769 | 0.530 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 622 | 0.510 |
Why?
|
| Gene Rearrangement | 2 | 2015 | 326 | 0.510 |
Why?
|
| Genome, Human | 6 | 2025 | 1322 | 0.500 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2016 | 107 | 0.480 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2019 | 470 | 0.480 |
Why?
|
| Mutation | 12 | 2025 | 6131 | 0.480 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1080 | 0.470 |
Why?
|
| Exons | 4 | 2025 | 764 | 0.470 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 44 | 0.460 |
Why?
|
| Membrane Proteins | 4 | 2019 | 1602 | 0.450 |
Why?
|
| Alleles | 4 | 2026 | 1685 | 0.440 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 714 | 0.410 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2015 | 237 | 0.400 |
Why?
|
| Exome | 6 | 2022 | 1075 | 0.390 |
Why?
|
| Chromosome Aberrations | 5 | 2022 | 575 | 0.390 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 2110 | 0.390 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 656 | 0.370 |
Why?
|
| Phenotype | 8 | 2020 | 4474 | 0.360 |
Why?
|
| Trans-Activators | 3 | 2025 | 705 | 0.360 |
Why?
|
| Mouth Neoplasms | 2 | 2023 | 93 | 0.350 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2022 | 569 | 0.350 |
Why?
|
| Tumor Microenvironment | 4 | 2025 | 698 | 0.350 |
Why?
|
| Humans | 44 | 2026 | 130418 | 0.320 |
Why?
|
| Genomic Instability | 3 | 2022 | 244 | 0.300 |
Why?
|
| Homologous Recombination | 2 | 2022 | 99 | 0.300 |
Why?
|
| DNA Replication | 4 | 2019 | 358 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 633 | 0.260 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2023 | 754 | 0.260 |
Why?
|
| Mosaicism | 2 | 2022 | 250 | 0.260 |
Why?
|
| Adolescent | 10 | 2026 | 20754 | 0.240 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2025 | 103 | 0.220 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2025 | 24 | 0.220 |
Why?
|
| Smoke | 1 | 2025 | 81 | 0.220 |
Why?
|
| Adenosine Triphosphatases | 2 | 2016 | 189 | 0.220 |
Why?
|
| Female | 22 | 2026 | 70285 | 0.210 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2025 | 59 | 0.210 |
Why?
|
| Genomic Structural Variation | 2 | 2015 | 95 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2022 | 17614 | 0.210 |
Why?
|
| Child, Preschool | 11 | 2021 | 14985 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 93 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 3425 | 0.210 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 195 | 0.200 |
Why?
|
| Base Sequence | 4 | 2022 | 2767 | 0.200 |
Why?
|
| Population Health | 1 | 2024 | 35 | 0.200 |
Why?
|
| Pedigree | 8 | 2021 | 1683 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 1 | 2025 | 231 | 0.190 |
Why?
|
| Male | 21 | 2026 | 64527 | 0.190 |
Why?
|
| Pharmacogenetics | 1 | 2024 | 203 | 0.190 |
Why?
|
| Meningioma | 1 | 2025 | 148 | 0.190 |
Why?
|
| Child | 11 | 2025 | 26165 | 0.190 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 242 | 0.190 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2018 | 1006 | 0.190 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 220 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 726 | 0.180 |
Why?
|
| Genes, ras | 1 | 2022 | 98 | 0.180 |
Why?
|
| Nervous System Diseases | 2 | 2016 | 395 | 0.180 |
Why?
|
| Muscular Diseases | 1 | 2022 | 124 | 0.170 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 9 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2024 | 381 | 0.160 |
Why?
|
| Megalencephaly | 1 | 2021 | 61 | 0.160 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 773 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2025 | 1972 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 1723 | 0.160 |
Why?
|
| Neutrophils | 1 | 2022 | 359 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 379 | 0.150 |
Why?
|
| Actins | 1 | 2021 | 315 | 0.150 |
Why?
|
| Cytokines | 2 | 2023 | 1335 | 0.150 |
Why?
|
| Infant | 11 | 2022 | 13269 | 0.150 |
Why?
|
| Chromosome Inversion | 2 | 2016 | 72 | 0.150 |
Why?
|
| Young Adult | 6 | 2026 | 9995 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2026 | 891 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2025 | 4674 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 96 | 0.140 |
Why?
|
| Models, Genetic | 3 | 2017 | 748 | 0.140 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.140 |
Why?
|
| Germ Cells | 2 | 2022 | 200 | 0.140 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 52 | 0.140 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 123 | 0.140 |
Why?
|
| Gametogenesis | 2 | 2017 | 26 | 0.140 |
Why?
|
| Homozygote | 2 | 2017 | 539 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2018 | 5069 | 0.140 |
Why?
|
| Germ-Line Mutation | 2 | 2025 | 373 | 0.140 |
Why?
|
| Microcephaly | 1 | 2021 | 347 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 490 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 133 | 0.140 |
Why?
|
| Animals | 9 | 2025 | 33889 | 0.130 |
Why?
|
| Alu Elements | 2 | 2015 | 66 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2025 | 1556 | 0.130 |
Why?
|
| Texas | 1 | 2026 | 3626 | 0.130 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2015 | 439 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1229 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 583 | 0.130 |
Why?
|
| SUMO-1 Protein | 1 | 2016 | 10 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 2847 | 0.120 |
Why?
|
| Facies | 1 | 2017 | 157 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2018 | 739 | 0.120 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 149 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2018 | 597 | 0.120 |
Why?
|
| Adult | 7 | 2026 | 31127 | 0.120 |
Why?
|
| Sumoylation | 1 | 2016 | 48 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2020 | 931 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2017 | 177 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 1443 | 0.110 |
Why?
|
| Primates | 1 | 2015 | 81 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 311 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 98 | 0.110 |
Why?
|
| Acromegaly | 1 | 2015 | 10 | 0.110 |
Why?
|
| Mice | 5 | 2025 | 18185 | 0.110 |
Why?
|
| Gigantism | 1 | 2015 | 14 | 0.110 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2015 | 22 | 0.110 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2015 | 27 | 0.110 |
Why?
|
| Campomelic Dysplasia | 1 | 2014 | 4 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 6781 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 599 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 278 | 0.110 |
Why?
|
| Foot Deformities, Congenital | 1 | 2014 | 16 | 0.110 |
Why?
|
| Fibula | 1 | 2014 | 20 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 914 | 0.110 |
Why?
|
| Toes | 1 | 2014 | 28 | 0.110 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.110 |
Why?
|
| Fibrillar Collagens | 1 | 2014 | 14 | 0.110 |
Why?
|
| Founder Effect | 1 | 2014 | 32 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 267 | 0.110 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2014 | 30 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2016 | 207 | 0.110 |
Why?
|
| Fingers | 1 | 2014 | 63 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 361 | 0.100 |
Why?
|
| Haplotypes | 1 | 2015 | 522 | 0.100 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 422 | 0.100 |
Why?
|
| Tibia | 1 | 2014 | 86 | 0.100 |
Why?
|
| Osteochondrodysplasias | 1 | 2014 | 68 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 101 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 454 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2022 | 752 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 384 | 0.100 |
Why?
|
| Cell Movement | 1 | 2016 | 871 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 246 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 5186 | 0.090 |
Why?
|
| Computational Biology | 1 | 2017 | 868 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 445 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 763 | 0.080 |
Why?
|
| Aged | 3 | 2026 | 20894 | 0.080 |
Why?
|
| Karyotyping | 2 | 2022 | 312 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4656 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1875 | 0.070 |
Why?
|
| Databases, Genetic | 2 | 2025 | 507 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2025 | 568 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 348 | 0.070 |
Why?
|
| Middle Aged | 2 | 2026 | 28383 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2025 | 8493 | 0.060 |
Why?
|
| Chromosome Breakpoints | 2 | 2017 | 82 | 0.060 |
Why?
|
| Prognosis | 1 | 2015 | 4894 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3507 | 0.060 |
Why?
|
| Janus Kinase 3 | 1 | 2025 | 16 | 0.060 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2025 | 14 | 0.060 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2025 | 23 | 0.060 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2025 | 27 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 359 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2025 | 89 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 39 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2024 | 47 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 64 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2015 | 585 | 0.050 |
Why?
|
| Neonatal Screening | 1 | 2025 | 201 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 3186 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 2017 | 521 | 0.050 |
Why?
|
| Genetic Loci | 2 | 2015 | 356 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2020 | 850 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 2408 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 116 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 88 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 78 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2025 | 435 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2025 | 342 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2022 | 208 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 1004 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2021 | 87 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 145 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 463 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2020 | 245 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 132 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 339 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 346 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 236 | 0.040 |
Why?
|
| Neurons | 2 | 2020 | 2010 | 0.040 |
Why?
|
| Neuroglia | 1 | 2020 | 223 | 0.040 |
Why?
|
| Genotype | 2 | 2014 | 2605 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 623 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 419 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 111 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 653 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1419 | 0.030 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 5 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 100 | 0.030 |
Why?
|
| A549 Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 119 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1666 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 129 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 49 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2016 | 83 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 255 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 44 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 140 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 203 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 57 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 876 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 199 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 310 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 698 | 0.030 |
Why?
|
| Spastin | 1 | 2014 | 8 | 0.030 |
Why?
|
| Prostaglandins F | 1 | 2014 | 8 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 786 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 49 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 60 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 160 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2014 | 156 | 0.030 |
Why?
|
| Clone Cells | 1 | 2014 | 152 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 155 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 80 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2014 | 138 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1160 | 0.030 |
Why?
|
| Axons | 1 | 2016 | 387 | 0.020 |
Why?
|
| Adenoma | 1 | 2015 | 145 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 419 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 134 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 721 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 541 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 729 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 324 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 1090 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 749 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 857 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 823 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 694 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 515 | 0.020 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 621 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1482 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2919 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1680 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11827 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2476 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 6423 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7380 | 0.010 |
Why?
|